Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in the United States, dedicated to discovering and advancing novel therapeutic agents for immune-inflammatory diseases. The company operates through two distinct divisions: Therapeutics and Contract Research. The Therapeutics segment focuses on identifying and developing cutting-edge treatments to address significant unmet medical needs within the realm of immunological and inflammatory conditions.